SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-037486
Filing Date
2019-10-23
Accepted
2019-10-23 09:32:10
Documents
81
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-10q_20190930.htm   iXBRL 10-Q 3808100
2 EX-31.1 alks-ex311_6.htm EX-31.1 19044
3 EX-31.2 alks-ex312_7.htm EX-31.2 19445
4 EX-32.1 alks-ex321_8.htm EX-32.1 14700
5 GRAPHIC gnhdway4fzer000002.jpg GRAPHIC 22345
6 GRAPHIC gnhdway4fzer000003.jpg GRAPHIC 4602
7 GRAPHIC gnhdway4fzer000001.jpg GRAPHIC 3161
  Complete submission text file 0001564590-19-037486.txt   12560515

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA alks-20190930.xsd EX-101.SCH 59614
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alks-20190930_cal.xml EX-101.CAL 80025
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alks-20190930_def.xml EX-101.DEF 199453
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20190930_lab.xml EX-101.LAB 483962
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20190930_pre.xml EX-101.PRE 363427
38 EXTRACTED XBRL INSTANCE DOCUMENT alks-10q_20190930_htm.xml XML 2862210
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 191162859
SIC: 2834 Pharmaceutical Preparations